Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378.
作者信息
Blervaque Julie, Lablanche Sandrine, Romero-Ugalde Hector, Adenis Alice, Charpentier Guillaume, Benhamou Pierre Yves
机构信息
Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, Grenoble, France.
Diabeloop SA, Grenoble, France.
出版信息
Diabetes Care. 2023 Oct 1;46(10):e207-e208. doi: 10.2337/dc23-1243.
Abstract
摘要
相似文献
1
Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378.对海达尔等人的评论。一项随机交叉试验，比较1型糖尿病患者中自动胰岛素输注（人工胰腺）与碳水化合物计数或简化的定性餐量估计。《糖尿病护理》2023年；46:1372 - 1378。
Diabetes Care. 2023 Oct 1;46(10):e207-e208. doi: 10.2337/dc23-1243.
2
A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.一项比较自动化胰岛素输注（人工胰腺）与碳水化合物计数或简化定性膳食估计在 1 型糖尿病中应用的随机交叉试验。
Diabetes Care. 2023 Jul 1;46(7):1372-1378. doi: 10.2337/dc22-2297.
3
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.使用闭环自动化胰岛素输送（人工胰腺）和恩格列净减少 1 型糖尿病患者对碳水化合物计数的需求：一项随机、对照、非劣效、交叉先导试验。
Diabetes Obes Metab. 2021 Jun;23(6):1272-1281. doi: 10.1111/dom.14335. Epub 2021 Feb 28.
4
Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.双激素人工胰腺减轻1型糖尿病碳水化合物计数负担的疗效：一项随机交叉试验。
Diabetes Metab. 2016 Feb;42(1):47-54. doi: 10.1016/j.diabet.2015.05.001. Epub 2015 Jun 10.
5
A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.全人工胰腺与混合人工胰腺治疗 1 型糖尿病的比较：一项单中心、开放标签、随机对照、交叉、非劣效性试验。
Lancet Digit Health. 2021 Nov;3(11):e723-e732. doi: 10.1016/S2589-7500(21)00139-4. Epub 2021 Sep 24.
6
Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.简化餐食告知与普兰林肽给药，与加拿大蒙特利尔的 1 型糖尿病患者应用自动化速效门冬胰岛素的碳水化合物计数法：一项随机交叉试验
Lancet Digit Health. 2024 Jul;6(7):e489-e499. doi: 10.1016/S2589-7500(24)00092-X.
7
Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study.仿生胰腺生成的备用胰岛素方案的实用性和安全性：一项随机研究。
Diabetes Technol Ther. 2023 Jun;25(6):437-441. doi: 10.1089/dia.2022.0461. Epub 2023 Mar 22.
8
Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.使用多种激素的成人1型糖尿病全自动人工胰腺：探索性实验
Can J Diabetes. 2021 Dec;45(8):734-742. doi: 10.1016/j.jcjd.2021.02.002. Epub 2021 Feb 20.
9
Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.用于1型糖尿病患者夜间血糖控制的单激素和双激素人工胰腺
J Clin Endocrinol Metab. 2016 Jan;101(1):214-23. doi: 10.1210/jc.2015-3003. Epub 2015 Nov 2.
10
Insulin therapy and carbohydrate counting.胰岛素治疗与碳水化合物计数
Acta Biomed. 2005;76 Suppl 3:44-8.
引用本文的文献
1
Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.在1型糖尿病青少年和青年中使用混合闭环胰岛素给药的简化餐食告知研究（SMASH）：一项随机对照双中心交叉试验
Diabetologia. 2025 Feb;68(2):295-307. doi: 10.1007/s00125-024-06319-w. Epub 2024 Nov 19.
本文引用的文献
1
A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.一项比较自动化胰岛素输注（人工胰腺）与碳水化合物计数或简化定性膳食估计在 1 型糖尿病中应用的随机交叉试验。
Diabetes Care. 2023 Jul 1;46(7):1372-1378. doi: 10.2337/dc22-2297.
2
One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany.DBLG1 闭环系统一年真实世界性能：来自德国 3706 名 1 型糖尿病成年患者的数据。
Diabetes Obes Metab. 2023 Jun;25(6):1607-1613. doi: 10.1111/dom.15008. Epub 2023 Feb 21.
3
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.真实环境中 1 型糖尿病成人闭环胰岛素输注：为期 12 周的多中心、开放标签随机对照交叉试验。
Lancet Digit Health. 2019 May;1(1):e17-e25. doi: 10.1016/S2589-7500(19)30003-2. Epub 2019 May 2.
Zotero 插件